 treatment uterin leiomyomata hormone-releas hormon agonist possibl nonsurg manag perimenopaus women object efficaci hormone-releas hormon agonist lh-rh-a treatment leiomyomata design retrospect trial set hospit depart obstetr gynecolog patient twenty-f women year symptomat uterin leiomyomata group respons lh-rh-a group patient lh-rh-a wherea resumpt menstruat week cessat therapi group intervent hormon agonist time day microgram insuffl spray nostril total dose micrograms/d main outcom measur efficaci treatment term uterin volum hemoglobin concentr serum level hormon LH follicle-stimul hormon fsh bone densiti treatment result group hemoglobin concentr week treatment signific reduct uterin volum group therapi signific chang uterin volum group wherea uterin volum group valu serum LH fsh concentr treatment gonadotropin group menopaus level treatment serum concentr group consist suppress end first treatment cycl cessat therapi serum level group castrat rang group pretreat level concomit return normal ovul conclus intranas administr lh-rh-a success uterin volum hemoglobin concentr premenopaus women leiomyomata